换一批Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
第一作者：
John,Frater
第一单位：
Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: john.frater@ndm.ox.ac.uk.
作者：
John,Frater [1]
;
Katie J,Ewer [2]
;
Ane,Ogbe [3]
;
Mathew,Pace [3]
;
Sandra,Adele [3]
;
Emily,Adland [4]
;
Jasmini,Alagaratnam [5]
;
Parvinder K,Aley [6]
;
Mohammad,Ali [3]
;
M Azim,Ansari [3]
;
Anna,Bara [7]
;
Mustapha,Bittaye [2]
;
Samantha,Broadhead [8]
;
Anthony,Brown [3]
;
Helen,Brown [3]
;
Federica,Cappuccini [2]
;
Enya,Cooney [8]
;
Wanwisa,Dejnirattisai [9]
;
Christina,Dold [6]
;
Cassandra,Fairhead [8]
;
Henry,Fok [8]
;
Pedro M,Folegatti [2]
;
Jamie,Fowler [2]
;
Charlotte,Gibbs [8]
;
Anna L,Goodman [8]
;
Daniel,Jenkin [2]
;
Mathew,Jones [3]
;
Rebecca,Makinson [2]
;
Natalie G,Marchevsky [6]
;
Yama F,Mujadidi [6]
;
Hanna,Nguyen [8]
;
Lucia,Parolini [3]
;
Claire,Petersen [5]
;
Emma,Plested [6]
;
Katrina M,Pollock [7]
;
Maheshi N,Ramasamy [6]
;
Sarah,Rhead [6]
;
Hannah,Robinson [6]
;
Nicola,Robinson [10]
;
Patpong,Rongkard [3]
;
Fiona,Ryan [8]
;
Sonia,Serrano [11]
;
Timothy,Tipoe [3]
;
Merryn,Voysey [6]
;
Anele,Waters [8]
;
Panagiota,Zacharopoulou [3]
;
Eleanor,Barnes [12]
;
Susanna,Dunachie [13]
;
Philip,Goulder [14]
;
Paul,Klenerman [15]
;
Gavin R,Screaton [9]
;
Alan,Winston [5]
;
Adrian V S,Hill [2]
;
Sarah C,Gilbert [2]
;
Andrew J,Pollard [16]
;
Sarah,Fidler [5]
;
Julie,Fox [8]
;
Teresa,Lambe [2]
;
Oxford COVID Vaccine Trial Group
作者单位：
Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: john.frater@ndm.ox.ac.uk.
[1]
The Jenner Institute, University of Oxford, Oxford, UK.
[2]
Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
[3]
Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; Department of Paediatrics, University of Oxford, Oxford, UK.
[4]
Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK; Department of HIV Medicine, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
[5]
Nuffield Department of Clinical Medicine and Oxford Vaccine Group, University of Oxford, Oxford, UK.
[6]
NIHR Imperial Clinical Research Facility and NIHR Imperial Biomedical Research Centre, London, UK.
[7]
Department of Infection, Harrison Wing and NIHR Clinical Research Facility, Guys and St Thomas' NHS Trust, London, UK.
[8]
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
[9]
Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
[10]
NIHR Guy's and St Thomas' Biomedical Research Centre, London, UK.
[11]
Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; The Jenner Institute, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
[12]
Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK; Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
[13]
Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; Department of Paediatrics, University of Oxford, Oxford, UK.
[14]
Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
[15]
Nuffield Department of Clinical Medicine and Oxford Vaccine Group, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
[16]
医学主题词
成年人(Adult);抗体, 病毒(Antibodies, Viral);CD4淋巴细胞计数(CD4 Lymphocyte Count);HIV感染(HIV Infections);人类(Humans);男(雄)性(Male);中年人(Middle Aged);接种(Vaccination)
DOI
10.1016/S2352-3018(21)00103-X
PMID
34153264
发布时间
2025-05-30
- 浏览2
The lancet. HIV
The lancet. HIV
2021年8卷8期
e474-e485页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
